胃癌的诊断与治疗(二)——晚期胃癌的治疗现状
被引量:6
摘要
迄今晚期胃癌化疗作用仍属姑息性。传统的化疗方案治疗比最好的支持治疗的中位生存期明显提高,随着各种新的抗癌药物的出现,晚期胃癌治疗的有效率和生存期有望进一步提高,但目前尚无标准的联合治疗方案。尤其近年来靶向治疗药物的引入有可能为胃癌的治疗开辟一条新的途径。
出处
《中国全科医学》
CAS
CSCD
2004年第22期1631-1634,共4页
Chinese General Practice
参考文献41
-
1Vanhoefer U,Rougier P,Wilke H,er al.Final results of a randomized phase IIItrial of sepuential high-dose methotrexate,fluorouracil,and doxorubicin versus etoposide,leucovorin,and fluourouracil versus infudional fluorouracil and cisplatin in advanced gastr
-
2Ohtsu A,Shimada Y,Shirao K,et al.Randomized phase III trial of fluorouracil versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer:The Japan Clinical Oncology Group study(JCOG9205)
-
3Ross P,Nicolson M,Cunningham D,et al.Proospective randomized trial comparing mitomycin,cisplatin,and protracted venous-infusionflurouracil(PVI 5-FU)with epirubicin,cisplatin,and PVI 5-FU in advancd esophagogastric cancer[J].J Clin Oncol,2002,20:1996-2004.
-
4Akata Y,Ohtsu A,Horikoshi N,et al.Late phase II study of novel oral fluoropyrimidine anticancer drug S-1(1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients[J].Eur J Cancer,1998,34:1715-1720.
-
5Evans TR,Pentheroudakis G,Paul J,et al.A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients ith inoperabli oesophago-gastric adenocarcinoma[J].Ann Oncol,2002,13:1469-1478.
-
6Ajani JA,Van Custem E,Moiseyenko FC,et al.Docetaxel(D),cisplatin,5-fluorouracil(F)for chemotherapy-naive patients with metastatic or locally recurrent,unresectable gastric carcinoma:Interim results of a randomized phase III trial(V 325)[J].Proc Am Soc Cli
-
7Pazzo C,Bugat R,Peschel C,et al.Irinotecan in combination with CDDP or 5-FU and folinic acid is active in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma:Final results of a randomized phase II study[J].Proc Am Soc Clin Oncol,2
-
8Chollet P,Schoffski P,Weigang-Kohler K,et al.Phase II trial of S-1 in chemotherapy-na?ve patients with gastric cancer.A trial performed by the EORTC Early Clinical Studies Group(ECSG)[J].Eur J Cancer,2003,39:1264-1270.
-
9Cascinu S,Labianca R,Alessandroni P,et al.Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil,cisplatin,epidoxorubicin,6S-leucovorin,glutathione,and filgrastim:a report from the Italian Group for the Study of Digestive Tract Cance
-
10Tebbutt NC.Randomized,multicenter phase III study comparing capecitabine with fluorouracil and oxalipltain with cisplatin in patients with advanced oesophago-gastric cancers:Interim analysis[J].Proc Am Soc Clin Oncol,2002,21:523.
同被引文献29
-
1杨力,王平.幽门螺杆菌抗体和血清胃蛋白酶原与慢性胃炎及胃癌的关系[J].河北医药,2004,26(10):773-774. 被引量:13
-
2冯强,袁兴华.胃癌的外科治疗[J].中国全科医学,2004,7(22):1634-1635. 被引量:7
-
3张秋霞.泰素帝、草酸铂联合氟脲嘧啶/亚叶酸钙方案治疗晚期胃癌临床观察[J].河北医药,2006,28(9):833-833. 被引量:2
-
4叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2002.392-402.
-
5巴亚萍.胃癌的病理特点[J].中国医药导报,2007,4(09X):146-147. 被引量:2
-
6Nishiyama Y,Koyama S,Andoh A,et al.Gastric inflanunatory fibroid polyp treated With Helicobacter pylori eradication therapy[J].Intern Med,2003,42:263.
-
7Wang L,Kitaichi K,Hui CS,et al.Reversal of anticancer drug resistance by macroide Antibiotics in vitro and in vivo[J].Clin Exp Pharmocol Physiol,2000,27:587.
-
8Chan TA.Nonsteroidal anti-inflammatory drugs,apoptosis,and colon-cancer chemoprevention[J].Lancet Oncol,2002,3:166.
-
9Aoki K,Kawai H,Sato H.Suppressive effect of erythromycin on LPS-induced NF-kappaB activation in mouse lung[J].Jpn J Antibiot,2003,56(Suppl A):106.
-
10Hamada K,Mikasa K,Yunou Y,et al.Adjuvant effect of clarithromycin on chemotherapy for murine Lung Cancer[J].Chemotherapy,2000,46:49.
引证文献6
-
1王文彦.胃癌术后复发治疗28例分析[J].中国误诊学杂志,2006,6(2):312-312. 被引量:2
-
2邓国林,闵广斌.128例早期胃癌临床诊治分析[J].实用中西医结合临床,2007,7(3):48-49. 被引量:1
-
3张静.克拉霉素对晚期胃癌的治疗作用[J].中国全科医学,2007,10(11):936-937. 被引量:1
-
4石国范,王雪莹.128例早期胃癌临床分析[J].中国现代医生,2008,46(18):120-120. 被引量:1
-
5韩晓强,王峰.老年人胃癌65例手术治疗分析[J].中国基层医药,2009,16(6):981-982. 被引量:2
-
6李卫威,智晓玉,胡毅.卡培他滨治疗晚期胃癌对肠黏膜屏障功能及血清肿瘤标志物水平的影响[J].中国临床医生杂志,2019,47(2):155-158. 被引量:14
二级引证文献21
-
1陈中建.残胃复发癌再手术24例分析[J].中国误诊学杂志,2007,7(16):3800-3800. 被引量:1
-
2余海琳.国内克拉霉素临床应用概述[J].今日药学,2008,18(5):8-10. 被引量:3
-
3朱黎明,王碧君,包玉洁,杨文燕,戴强,江佛湖,吴云林.早期胃癌的胃镜特征与病理分析[J].内科理论与实践,2010,5(3):240-242. 被引量:2
-
4伍崇敏,潘光明,李福年.胃癌术后复发再手术治疗研究[J].中国医药指南,2010,8(20):197-198. 被引量:5
-
5肖磊.胃癌全胃切除术后消化道重建术式的比较[J].中国基层医药,2011,18(22):3120-3121. 被引量:5
-
6沈象吉.不同消化道重建方式在胃肠手术中的应用研究[J].求医问药(下半月刊),2012,10(10):462-463. 被引量:2
-
7张慧青.826例胃癌的临床分析[J].中国当代医药,2013,20(8):47-48. 被引量:4
-
8冯兴华.血清CYFRA21-1检测对临床胃癌的诊断价值分析[J].世界复合医学,2019,5(8):120-122.
-
9金京哲.卡培他滨维持化疗治疗晚期胃癌的疗效观察[J].医学食疗与健康,2019,0(11):64-64. 被引量:2
-
10陈阵.温脾养胃汤辅助三联疗法治疗脾胃虚寒型幽门螺杆菌感染慢性胃炎的效果[J].河南医学研究,2020,29(24):4546-4548. 被引量:8
-
1王玲.腹腔镜治疗卵巢良性肿瘤的临床疗效分析[J].中国社区医师(医学专业),2012,14(32):127-128. 被引量:1
-
2吴杨.肺癌的治疗进展[J].医学美学美容(中旬刊),2014,23(3):461-462.
-
3梅朝蓉,侯梅,朱江,勾红峰,鄢希,李潞,丘萌.奥沙利铂联合氟尿嘧啶和亚叶酸钙治疗晚期大肠癌[J].四川肿瘤防治,2004,17(1):9-10.
-
4张璐.肿瘤分子靶向治疗药物概述[J].中国实用乡村医生杂志,2017,24(4):12-14. 被引量:3
-
5程欣,黄颖,刘宁.基质金属蛋白酶-9与结直肠癌[J].国际肿瘤学杂志,2016,43(7):538-540. 被引量:1
-
6游经宏,周凯,邓莫根,谭晓萍,袁喜红.肝细胞癌切除术后预后因素分析[J].江西医药,2010,45(6):511-513. 被引量:5
-
7乔华,于爱珍,王萍,包兴才.晚期非小细胞肺癌治疗进展[J].医学综述,2003,9(12):740-742. 被引量:1
-
8赵小强,岳晶晶,阮林海.硼替佐米为主的化疗方案治疗多发性骨髓瘤的疗效和安全性观察[J].临床合理用药杂志,2016,9(22):90-91. 被引量:2
-
9沈益君,叶定伟.浸润性膀胱癌保留膀胱的综合治疗进展[J].中国癌症杂志,2007,17(3):265-268. 被引量:7
-
10张筱茵,樊代明,周绍娟,陈峥.人胃癌细胞引入鼠基因作为靶细胞的研究[J].第四军医大学学报,1996,17(4):305-306.